Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



New Products

Related to Pharmaco (Epi)genomics Center Launched

    • Methylation Analysis
    • Zymo Research
    • The EZ DNA Methylation-Lightning kit is for complete bisulfite conversion of DNA prior to methylation analysis by PCR, MSP, array, or next-gen sequencing. The ready-to-use liquid-format Lightning conversion reagent is added directly to a DNA sample
    • Genome Mapping System
    • BioNano Genomics
    • The Irys™ is a genome mapping system that can help genomics researchers with structural variation analysis and sequence assemblies. Irys is an automated platform that uses single-molecule imaging to visualize extremely long nucleic acids and reveal
    • Genetic Analyzer
    • Pacific Biosciences
    • The PacBio® RS high-resolution genetic analyzer has undergone a software upgrade featuring additional tools for performing DNA base modification analysis and de novo genome assembly. With the release of the SMRT Analysis 1.3.3 software upgrade
    • Stabilized Pepsin
    • SciGene
    • CytoZyme™ stabilized pepsin is an advanced formulation for pretreating tissue samples in nucleic acid probe-based cytogenetic assays including FISH. CytoZyme is a ready-to-use solution of purified pepsin that can be stored in the refrigerator witho
    • Epigenetics Conjugates
    • Cisbio Bioassays
    • The epigenetics toolbox is a selection of conjugates specifically developed for epigenetics studies to help pharmaceutical and biotechnology researchers better understand how these events occur through epigenetic mechanisms and how they relate
    • Methylated Gene Targeting
    • Cellectis bioresearch
    • TALEN™ CpG™ is a service designed to overcome the impact of methylated DNA on TALEN nuclease activity. Users can target any gene at any position in any cell type regardless of methylation status. The service can make gene editing accessible for the
  • Page 1 of 1 (7 items) 1 

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll